Association of Blood Biochemical Indexes and Antibiotic Exposure With Severe Immune-related Adverse Events in Patients With Advanced Cancers Receiving PD-1 Inhibitors

Some patients with cancer treated with programmed death 1 (PD-1) inhibitors experience immune-related severe adverse events (ir-SAEs), however, predictors are limited. The objective was to identify clinicopathologic features that may be associated with a higher ir-SAE risk. This was a nested case-co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lijun, Li, Yang, Jiang, Ning, Song, Xue, Xu, Jianhua, Zhu, Xiangzhi, Chen, Cheng, Kong, Cheng, Wang, Xiaohua, Zong, Dan, Li, Luan, Han, Cen, Yin, Li, He, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986630/
https://www.ncbi.nlm.nih.gov/pubmed/35250004
http://dx.doi.org/10.1097/CJI.0000000000000415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986630/
https://www.ncbi.nlm.nih.gov/pubmed/35250004
http://dx.doi.org/10.1097/CJI.0000000000000415

Ejemplares similares